Neuren Pharmaceuticals Limited (ASX: NEU)

Neuren Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2,541	3,154	1,001	444	138	248
Market Cap Growth	549.68%	214.94%	125.55%	221.49%	-44.41%	79.16%
Enterprise Value	2,312	3,137	961	407	114	235
PE Ratio	16.61	20.08	5442.54	-56.97	-15.02	-22.97
PS Ratio	10.95	13.60	68.81	138.88	192.61	501.85
PB Ratio	12.38	15.37	24.08	11.31	5.71	17.94
P/FCF Ratio	13.74	17.06	279.73	-44.49	-17.08	-21.18
P/OCF Ratio	17.08	17.05	278.25	-44.53	-17.10	-21.20
EV/Sales Ratio	9.97	13.52	66.05	127.37	158.88	473.89
EV/EBITDA Ratio	11.60	15.74	-606.08	-35.65	-11.97	-20.28
EV/EBIT Ratio	11.60	15.74	-602.29	-35.63	-11.96	-20.27
EV/FCF Ratio	12.51	16.97	268.50	-40.80	-14.09	-20.00
Quick Ratio	5.68	5.68	24.59	47.58	33.12	25.75
Current Ratio	5.78	5.78	25.77	49.87	33.12	25.75
Asset Turnover	1.33	0.94	0.34	0.08	0.03	0.03
Return on Equity (ROE)	76.55%	76.55%	0.44%	-19.86%	-37.99%	-78.11%
Return on Assets (ROA)	63.35%	63.35%	0.43%	-19.46%	-36.84%	-75.08%
Return on Capital (ROIC)	74.35%	74.35%	-3.84%	-29.12%	-39.36%	-83.56%
Earnings Yield	6.18%	4.98%	0.02%	-1.76%	-6.66%	-4.35%
FCF Yield	7.28%	5.86%	0.36%	-2.25%	-5.85%	-4.72%
Buyback Yield / Dilution	-1.64%	-1.44%	-9.46%	-10.01%	-6.88%	-0.42%
Total Shareholder Return	-1.64%	-1.44%	-9.46%	-10.01%	-6.88%	-0.42%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.